Evidence map›Paper›PMID 40133417›Full record

ArticleScientific reports2025

Nonwoven fabric coated with cerium oxide nanoparticles for viral inactivation and transmission Inhibition.

Eisuke Umezawa, Kan Fujino, Hiroko Ito Yamanaka, Shota Sekiguchi, Takahiro Motoshiromizu, Miho Kawanishi Ouchi, Shunsuke Murai, Tomohide Masuda, Masateru Ito, Hitoshi Nobumasa and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eisuke UmezawaLaboratory of Microbiology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
Kan FujinoLaboratory of Microbiology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan. k-fujino@azabu-u.ac.jp.
Hiroko Ito YamanakaLaboratory of Microbiology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.
Shota SekiguchiNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Takahiro MotoshiromizuNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Miho Kawanishi OuchiNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Shunsuke MuraiNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Tomohide MasudaNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Masateru ItoNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Hitoshi NobumasaNew Frontiers Research Laboratories, Toray Industries, Inc, 6-10-1, Kamakura, 248-8555, Kanagawa, Japan.
Satoshi TaharaguchiLaboratory of Microbiology, School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan.

Funding

New Energy and Industrial Technology Development Organization (NEDO, Japan) JPNP14004
6 · The paper itself

Abstract

Studies on virus inactivation by metal nanoparticles indicate that antiviral activity is influenced by the stabilizer on the particle surface. Additionally, cerium oxide nanoparticles stabilized with boric acid (BA-CeO

Indexed as

Antiviral AgentsCeriumMetal NanoparticlesNanoparticlesTextilesVirus InactivationAnimalsCalicivirus, FelineCatsInfluenza A virusMiceMurine hepatitis virusAntiviral Agentsceric oxideCeriumAntiviral materialCerium oxide nanoparticleNanoceriaNonwoven fabric

Identifiers

PMID40133417
PMCPMC11937568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.